Human atrial natriuretic peptide suppresses torsades de pointes in rabbits.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Circulation Journal

• Publication date

  2008-04-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1253/CIRCJ.72.820PMID 18441465
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atrial natriuretic peptide (ANP) suppresses acute atrial electrical remodeling in the canine rapid atrial stimulation model.

  2008cited by this paper
• Relevance of Brain Natriuretic Peptide in Preload-Dependent Regulation of Cardiac Sarcoplasmic Reticulum Ca2+ ATPase Expression

  2006cited by this paper
• Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs.

  2000cited by this paper
• Suppression of cesium-induced ventricular tachyarrhythmias by atrial natriuretic peptide in rabbits.

  2000cited by this paper
• Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.

  1999cited by this paper
• Effects of class III antiarrhythmic agents in an in vitro rabbit model of spontaneous torsades de pointe.

  1999cited by this paper
• Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.

  1999cited by this paper
• Effect of Atrial Natriuretic Peptide on Electrical Defibrillation Efficacy

  1998cited by this paper
• Atrial natriuretic peptide stimulates Na+‐dependent Ca2+ efflux from freshly isolated adult rat cardiomyocytes

  1997cited by this paper
• The roles of ion channels in an inherited heart disease: molecular genetics of the long QT syndrome.

  1996cited by this paper
• Mechanisms and management of congenital and acquired long QT syndromes.

  1996cited by this paper
• Enhancement of the L-type Ca2+ current by mechanical stimulation in single rabbit cardiac myocytes.

  1996cited by this paper
• Comparative study of cardiac electrophysiological effects of atrial natriuretic peptide

  1996cited by this paper
• Atrial Natriuretic Peptide and Cardiac Electrophysiology: Autonomic and Direct Effects

  1996cited by this paper
• Inhibitory effect of atrial natriuretic factor on sympathetic ganglionic neurotransmission in humans.

  1995cited by this paper
• Cyclic GMP‐mediated inhibition of L‐type Ca2+ channel activity by human natriuretic peptide in rabbit heart cells

  1995cited by this paper
• Efficacy of prolonged infusion of urodilatin [ANP-(95-126)] in patients with congestive heart failure.

  1995cited by this paper
• A new class III antiarrhythmic drug, MS-551, blocks the inward rectifier potassium channel in isolated guinea pig ventricular myocytes.

  1995cited by this paper
• The beneficial effects of atrial natriuretic peptide on arrhythmias and myocardial high-energy phosphates after reperfusion.

  1994cited by this paper
• The L-type calcium channel current is increased by alpha-1 adrenoceptor activation in neonatal rat ventricular cells.

  1994cited by this paper
• Electrophysiological Effects of atrial Natriuretic Peptide on the Cardiac Conduction System in Man

  1993cited by this paper
• Atrial natriuretic factor blocks the high-threshold Ca2+ current and increases K+ current in fetal single ventricular cells.

  1993cited by this paper
• Effects of MS‐551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes

  1993cited by this paper
• Effects of atrionatriuretic factor on Ca2+current and Cai-independent transient outward K+ current in human atrial cells

  1992cited by this paper
• Effects of atrial natriuretic peptide on myocardial contractile and diastolic function in patients with heart failure.

  1992cited by this paper
• Sympathoinhibitory effects of atrial natriuretic factor in normal humans.

  1990cited by this paper
• QTU‐Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the Rabbit: Etiology and Interventions

  1990cited by this paper
• Alpha adrenoceptor stimulation reduces outward currents in rat ventricular myocytes.

  1989cited by this paper
• The biochemical pharmacology of atrial peptides.

  1989cited by this paper
• Effects of Atrial Natriuretic Peptide on Ischaemia‐Induced Arrhythmias in the Rat Heart: Arrhythmogen or Endogenous Antiarrhythmic Agent?

  1989cited by this paper
• Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.

  1987cited by this paper
• alpha-ANP alters reflex control of lumbar and renal sympathetic nerve activity and heart rate.

  1987cited by this paper
• Contraction-excitation feedback in myocardium. Physiological basis and clinical relevance.

  1982cited by this paper

• Atrial natriuretic peptide accelerates onset and dynamics of ventricular fibrillation during hypokalemia in isolated rabbit hearts.

  2020cites this paper
• Effects of wildtype and mutant forms of atrial natriuretic peptide on L-type Ca2+ current in mouse atrial myocytes

  2016cites this paper
• Hydralazine inhibits ventricular tachyarrhythmias in an acquired long QT rabbit model

  2014cites this paper
• Dexmedetomidine and clonidine inhibit ventricular tachyarrhythmias in a rabbit model of acquired long QT syndrome.

  2012cites this paper
• Deep anesthesia suppresses ventricular tachyarrhythmias in rabbit model of the acquired long QT syndrome.

  2011cites this paper
• Endogenous cardiac natriuretic peptides protect the heart in a mouse model of dilated cardiomyopathy and sudden death.

  2009cites this paper
• Sensitive and reliable proarrhythmia in vivo animal models for predicting drug‐induced torsades de pointes in patients with remodelled hearts

  2008cites this paper